Montelukast, levocetirizine (Lumont Co, Montecet)
Montelukast, levocetirizine
Zydus Healthcare (Pty) Ltd
Registration
- Applicant
- Zydus Healthcare (Pty) Ltd
- Registrations
- 2
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Lumont co EACH TABLET CONTAINS MONTELUKAST SODIUM EQUIVALENT TO MONTELUKAST 10,0 mg LEVOCETIRIZINE DIHYDROCHLORIDE 5,0 mg | Not listed | 54017454/5.7.1/0174 | Registered | Not determined | None |
| Montecet EACH TABLET CONTAINS MONTELUKAST SODIUM EQUIVALENT TO MONTELUKAST 10,0 mg LEVOCETIRIZINE DIHYDROCHLORIDE 5,0 mg | Not listed | 540175.17454/5.7.1/0175.174 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S3: Montelukast
Consolidated Schedules 06 July 2026, line 3967
S1: Levocetirizine
Consolidated Schedules 06 July 2026, line 775
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.